ANIX Insider Trading Activity and SEC Form 4 Filings
ANIX insider trading summary
Over the past 12 months, insiders at Anixa Biosciences Inc (ANIX) reported 19 open-market purchases worth $496K by 4 insiders and no sales on SEC Form 4. Net insider buying was $496K.
Latest ANIX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 30, 2026 | Amit Kumar | Chief Executive Officer | Buy | $16K (5,000 @ $3.17) |
| Oct 23, 2026 | Lewis H Titterton jr | Director | Buy | $24K (8,000 @ $2.98) |
| Oct 22, 2026 | Amit Kumar | Chief Executive Officer | Buy | $22K (8,000 @ $2.72) |
| Sep 30, 2026 | Michael Catelani | President, COO, & CFO | Buy | $16K (5,500 @ $2.84) |
| Sep 24, 2026 | Arnold M Baskies | Director | Buy | $14K (5,000 @ $2.76) |
| Sep 24, 2026 | Amit Kumar | Chief Executive Officer | Buy | $19K (7,000 @ $2.78) |
| Sep 23, 2026 | Lewis H Titterton jr | Director | Buy | $132K (49,036 @ $2.69) |
| Sep 10, 2026 | Amit Kumar | Chief Executive Officer | Buy | $8K (3,000 @ $2.75) |
| Sep 10, 2026 | Lewis H Titterton jr | Director | Buy | $27K (10,000 @ $2.73) |
| Sep 10, 2026 | Amit Kumar | Chief Executive Officer | Buy | $14K (5,000 @ $2.76) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.